CERIVASTATIN SODIUM | BAYER PHARMS | ||
0.05MG,0.1MG,0.2MG,0.3MG,0.4MG,0.8MG | |||
No | No | ||
2011-Nov-26 | Expired | ||
None | None | ||
None | No | ||
BAYCOL® (cerivastatin sodium tablets) is indicated as an adjunct to diet to reduce elevated Total-C, LDLC, apo B, and TG and to increase HDL-C levels in patients with primary hypercholesterolemia and mixed dyslipidemia (Fredrickson Types IIa and IIb) when the response to dietary restriction of saturated fat and cholesterol and other non-pharmacological measures alone has been inadequate. |
0 | 0 | 0 |
Total Other Developers | None |
---|
Drugs with Suitability | No |
---|
0.05MG | ** | ** | - | - | - |
0.1MG | ** | ** | - | - | - |
0.2MG | ** | ** | - | - | - |
0.3MG | ** | ** | - | - | - |
0.4MG | ** | ** | - | - | - |
0.8MG | ** | ** | - | - | - |
NDA Sales Available | Total Generic Sales Available |
---|---|
No | 0 |
ANDA No | Generic Co | Manufacturer Name | Operations | Manufacturer Address | Country |
---|
Download GenUS Drug Report
Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023
+91 94997 68112
nimish@researchdelta.com